A retrograde trafficking inhibitor of ricin and Shiga-like toxins inhibits infection of cells by human and monkey polyomaviruses

mBio

Volumn 4, Issue 6, 2013, Pages

  Nelson, Christian D S ^a   Carney, Dan W ^b   Derdowski, Aaron ^a   Lipovsky, Alex ^c   Gee, Gretchen V ^a   O'Hara, Bethany ^a   Williard, Paul ^b   Dimaio, Daniel ^c,d   Sello, Jason K ^b   Atwood, Walter J ^a  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[(5 METHYL 2 THIENYL)METHYLENE]AMINO] N PHENYLBENZAMIDE; ANTITOXIN; RICIN; UNCLASSIFIED DRUG; VEROTOXIN; 2-(((5-METHYL-2-THIENYL)METHYLENE)AMINO)-N-PHENYLBENZAMIDE; ANTIVIRUS AGENT; BENZAMIDE DERIVATIVE; SHIGA TOXIN; THIOPHENE DERIVATIVE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BK VIRUS; CONTROLLED STUDY; DRUG STRUCTURE; DRUG TARGETING; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; INHIBITION KINETICS; JC VIRUS; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; SIMIAN VIRUS 40; VIRUS TRANSMISSION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; DRUG EFFECTS; HAPLORHINI; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT; VIRUS ENTRY;

ANIMALS; ANTIVIRAL AGENTS; BENZAMIDES; BK VIRUS; CELL LINE; HAPLORHINI; HUMANS; JC VIRUS; PROTEIN TRANSPORT; RICIN; SHIGA TOXINS; SIMIAN VIRUS 40; THIOPHENES; VIRUS INTERNALIZATION;

EID: 84891597724     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00729-13     Document Type: Article

References (58)

1. Jiang M, Abend JR, Johnson SF, Imperiale MJ. 2009. The role of polyomaviruses in human disease. Virology 384:266-273.
2. Kean JM, Rao S, Wang M, Garcea RL. 2009. Seroepidemiology of human polyomaviruses. PLoS Pathog. 5:e1000363. doi:10.1371/journal.ppat.1000363.
3. Monaco MC, Atwood WJ, Gravell M, Tornatore CS, Major EO. 1996. JC virus infection of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency. J. Virol. 70:7004-7012.
4. Monaco MC, Jensen PN, Hou J, Durham LC, Major EO. 1998. Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. J. Virol. 72:9918-9923.
5. Ferenczy MW, Marshall LJ, Nelson CD, Atwood WJ, Nath A, Khalili K, Major EO. 2012. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin. Microbiol. Rev. 25:471-506.
6. Shinohara T, Matsuda M, Cheng SH, Marshall J, Fujita M, Nagashima K. 1993. BK virus infection of the human urinary tract. J. Med. Virol. 41:301-305.
7. Knowles WA, Pipkin P, Andrews N, Vyse A, Minor P, Brown DW, Miller E. 2003. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J. Med. Virol. 71:115-123.
8. Kitamura T, Aso Y, Kuniyoshi N, Hara K, Yogo Y. 1990. High incidence of urinary JC virus excretion in nonimmunosuppressed older patients. J. Infect. Dis. 161:1128-1133.
9. Zurhein G, Chou SM. 1965. Particles resembling papova viruses in human cerebral demyelinating disease. Science 148:1477-1479.
10. Boothpur R, Brennan DC. 2010. Human polyoma viruses and disease with emphasis on clinical BK and JC. J. Clin. Virol. 47:306-312.
11. Binet I, Nickeleit V, Hirsch HH, Prince O, Dalquen P, Gudat F, Mihatsch MJ, Thiel G. 1999. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation 67:918-922.
12. Engel S, Heger T, Mancini R, Herzog F, Kartenbeck J, Hayer A, Helenius A. 2011. The role of endosomes in SV40 entry and infection. J. Virol. 85:4198-4211.
13. Querbes W, O'Hara BA, Williams G, Atwood WJ. 2006. Invasion of host cells by JC virus identifies a novel role for caveolae in endosomal sorting of noncaveolar ligands. J. Virol. 80:9402-9413.
14. Qian M, Cai D, Verhey KJ, Tsai B. 2009. A lipid receptor sorts polyomavirus from the endolysosome to the endoplasmic reticulum to cause infection. PLoS Pathog. 5:e1000465. doi:10.1371/journal.ppat.1000465.
15. Schelhaas M, Malmström J, Pelkmans L, Haugstetter J, Ellgaard L, Grünewald K, Helenius A. 2007. Simian virus 40 depends on ER protein folding and quality control factors for entry into host cells. Cell 131: 516-529.
16. Lilley BN, Gilbert JM, Ploegh HL, Benjamin TL. 2006. Murine polyomavirus requires the endoplasmic reticulum protein derlin-2 to initiate infection. J. Virol. 80:8739-8744.
17. Magnuson B, Rainey EK, Benjamin T, Baryshev M, Mkrtchian S, Tsai B. 2005. ERp29 triggers a conformational change in polyomavirus to stimulate membrane binding. Mol. Cell 20:289-300.
18. Rainey-Barger EK, Magnuson B, Tsai B. 2007. A chaperone-activated nonenveloped virus perforates the physiologically relevant endoplasmic reticulum membrane. J. Virol. 81:12996-13004.
19. Goodwin EC, Lipovsky A, Inoue T, Magaldi TG, Edwards AP, Van Goor KE, Paton AW, Paton JC, Atwood WJ, Tsai B, Dimaio D. 2011. BiP and multiple DNAJ molecular chaperones in the endoplasmic reticulum are required for efficient simian virus 40 infection. mBio 2:e00101-11. doi:10.1128/mBio.00101-11.
20. Stechmann B, Bai SK, Gobbo E, Lopez R, Merer G, Pinchard S, Panigai L, Tenza D, Raposo G, Beaumelle B, Sauvaire D, Gillet D, Johannes L, Barbier J. 2010. Inhibition of retrograde transport protects mice from lethal ricin challenge. Cell 141:231-242.
21. Lipovsky A, Popa A, Pimienta G, Wyler M, Bhan A, Kuruvilla L, Guie MA, Poffenberger AC, Nelson CD, Atwood WJ, Dimaio D. 2013. Genome-wide siRNA screen identifies the retromer as a cellular entry factor for human papillomavirus. Proc. Natl. Acad. Sci. U. S. A. 110: 7452-7457.
22. Meier O, Greber UF. 2004. Adenovirus endocytosis. J. Gene Med. 6(Suppl 1):S152-S163.
23. Gillet DBJ, Johnnes L, Stechmann B, Bai S. 23 December 2009. World Intellectual Property Organization patent WO2009153665A2.
24. Narasimhulu M, Lee YR. 2011. Ethylenediamine diacetate-catalyzed three-component reaction for the synthesis of 2,3-dihydroquinazolin-4(1H)-ones and their spirooxindole derivatives. Tetrahedron 67: 9627-9634.
25. Prakash M, Kesavan V. 2012. Highly enantioselective synthesis of 2,3-dihydroquinazolinones through intramolecular amidation of imines. Org. Lett. 14:1896-1899.
26. Sharma M, Pandey S, Chauhan K, Sharma D, Kumar B, Chauhan PM. 2012. Cyanuric chloride catalyzed mild protocol for synthesis of biologically active dihydro/spiro quinazolinones and quinazolinoneglycoconjugates. J. Org. Chem. 77:929-937.
27. Shaterian HR, Oveisi AR, Honarmand M. 2010. Synthesis of 2,3-dihydroquinazoline-4(1H)-ones. Synth. Commun. 40:1231-1242.
28. Wang M, Zhang TT, Liang Y, Gao JJ. 2011. Strontium chloride-catalyzed one-pot synthesis of 2,3-dihydroquinazolin-4(1H)-ones in protic media. Chin. Chem. Lett. 22:1423-1426.
29. Park JG, Kahn JN, Tumer NE, Pang YP. 2012. Chemical structure of retro-2, a compound that protects cells against ribosome-inactivating proteins. Sci. Rep. 2:631. doi:10.1038/srep00631.
30. Nelson CD, Derdowski A, Maginnis MS, O'Hara BA, Atwood WJ. 2012. The VP1 subunit of JC polyomavirus recapitulates early events in viral trafficking and is a novel tool to study polyomavirus entry. Virology 428: 30-40.
31. Norkin LC, Anderson HA, Wolfrom SA, Oppenheim A. 2002. Caveolar endocytosis of simian virus 40 is followed by brefeldin A-sensitive transport to the endoplasmic reticulum, where the virus disassembles. J. Virol. 76:5156-5166.
32. Tsai B, Qian M. 2010. Cellular entry of polyomaviruses. Curr. Top. Microbiol. Immunol. 343:177-194.
33. Sapp M, Day PM. 2009. Structure, attachment and entry of polyoma-and papillomaviruses. Virology 384:400-409.
34. DeCaprio JA, Garcea RL. 2013. A cornucopia of human polyomaviruses. Nat. Rev. Microbiol. 11:264-276.
35. Feng H, Shuda M, Chang Y, Moore PS. 2008. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096-1100.
36. Richards AA, Stang E, Pepperkok R, Parton RG. 2002. Inhibitors of COP-mediated transport and cholera toxin action inhibit simian virus 40 infection. Mol. Biol. Cell 13:1750-1764.
37. Gilbert J, Benjamin T. 2004. Uptake pathway of polyomavirus via ganglioside GD1a. J. Virol. 78:12259-12267.
38. Damm EM, Pelkmans L, Kartenbeck J, Mezzacasa A, Kurzchalia T, Helenius A. 2005. Clathrin-and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J. Cell Biol. 168: 477-488.
39. Barbier J, Bouclier C, Johannes L, Gillet D. 2012. Inhibitors of the cellular trafficking of ricin. Toxins (Basel) 4:15-27.
40. Lippincott-Schwartz J, Yuan LC, Bonifacino JS, Klausner RD. 1989. Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER. Cell 56: 801-813.
41. Huotari J, Helenius A. 2011. Endosome maturation. EMBO J. 30: 3481-3500.
42. Misumi Y, Miki K, Takatsuki A, Tamura G, Ikehara Y, Ikehara Y. 1986. Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. J. Biol. Chem. 261:11398-11403.
43. Low SH, Wong SH, Tang BL, Tan P, Subramaniam VN, Hong W. 1991. Inhibition by brefeldin A of protein secretion from the apical cell surface of Madin-Darby canine kidney cells. J. Biol. Chem. 266:17729-17732.
44. Johannes L, Römer W. 2010. Shiga toxins-from cell biology to biomedical applications. Nat. Rev. Microbiol. 8:105-116.
45. Ewers H, Helenius A. 2011. Lipid-mediated endocytosis. Cold Spring Harb. Perspect. Biol. 3(8):a004721. doi: 10.1101/cshperspect.a004721.
46. Low JA, Magnuson B, Tsai B, Imperiale MJ. 2006. Identification of gangliosides GD1b and GT1b as receptors for BK virus. J. Virol. 80: 1361-1366.
47. Campanero-Rhodes MA, Smith A, Chai W, Sonnino S, Mauri L, Childs RA, Zhang Y, Ewers H, Helenius A, Imberty A, Feizi T. 2007. N-glycolyl GM1 ganglioside as a receptor for simian virus 40. J. Virol. 81: 12846-12858.
48. Tsai B, Gilbert JM, Stehle T, Lencer W, Benjamin TL, Rapoport TA. 2003. Gangliosides are receptors for murine polyoma virus and SV40. EMBO J. 22:4346-4355.
49. Gorelik L, Reid C, Testa M, Brickelmaier M, Bossolasco S, Pazzi A, Bestetti A, Carmillo P, Wilson E, McAuliffe M, Tonkin C, Carulli JP, Lugovskoy A, Lazzarin A, Sunyaev S, Simon K, Cinque P. 2011. Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity. J. Infect. Dis. 204:103-114.
50. Sandvig K, Spilsberg B, Lauvrak SU, Torgersen ML, Iversen TG, van Deurs B. 2004. Pathways followed by protein toxins into cells. Int. J. Med. Microbiol. 293:483-490.
51. Johannes L, Popoff V. 2008. Tracing the retrograde route in protein trafficking. Cell 135:1175-1187.
52. Popoff V, Mardones GA, Tenza D, Rojas R, Lamaze C, Bonifacino JS, Raposo G, Johannes L. 2007. The retromer complex and clathrin define an early endosomal retrograde exit site. J. Cell Sci. 120:2022-2031.
53. Bonifacino JS, Hurley JH. 2008. Retromer. Curr. Opin. Cell Biol. 20: 427-436.
54. Chesters PM, Heritage J, McCance DJ. 1983. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J. Infect. Dis. 147:676-684.
55. Egli A, Infanti L, Dumoulin A, Buser A, Samaridis J, Stebler C, Gosert R, Hirsch HH. 2009. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J. Infect. Dis. 199: 837-846.
56. Knowles WA. 2006. Discovery and epidemiology of the human polyoma-viruses BK virus (BKV) and JC virus (JCV). Adv. Exp. Med. Biol. 577: 19-45.
57. Mallard F, Tang B, Galli T, Tenza Dl, Saint-Pol AS, Yuem X, Antony C, Hong W, Goud B, Johannes L. 2002. Early/recycling endosomes-to-TGN transport involves two SNARE complexes and a Rab6 isoform. J. Cell Biol. 156:653-664.
58. Amessou M, Fradagrada A, Falguières T, Lord JM, Smith DC, Roberts LM, Lamaze C, Johannes L. 2007. Syntaxin 16 and syntaxin 5 are required for efficient retrograde transport of several exogenous and endogenous cargo proteins. J. Cell Sci. 120:1457-1468.